Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Monitoring Treatment Response in Women With Breast Cancer Utilizing FLT-PET/CT

NCT01018251 is registered in ClinicalTrials.gov with Abramson Cancer Center at Penn Medicine as lead sponsor.

NCT NCT01018251
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01018251 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Monitoring Treatment Response in Women With Breast Cancer Utilizing FLT-PET/CT
Lead sponsor
Abramson Cancer Center at Penn Medicine
Phase
Not applicable
Overall status
Withdrawn
Start date
March 31, 2009
Completion date
June 30, 2011
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adult women with a new diagnosis of invasive breast cancer (have not undergone treatment)